SUGAR LAND--May 27, 2015--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--One of the Pharmaceutical-Biotech Industry's top three drug makers, Swiss-based Novartis International AG (NYSE:NVS) (Basel, has restructured its pharmaceuticals division by creating two business units--Novartis Pharmaceuticals and Novartis Oncology. Coinciding with the organizational split, the division head and chief executive officer of the company's Pharmaceuticals division, David Epstein, called it quits.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
